FI3501534T3 - Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia - Google Patents
Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia Download PDFInfo
- Publication number
- FI3501534T3 FI3501534T3 FIEP18209661.0T FI18209661T FI3501534T3 FI 3501534 T3 FI3501534 T3 FI 3501534T3 FI 18209661 T FI18209661 T FI 18209661T FI 3501534 T3 FI3501534 T3 FI 3501534T3
- Authority
- FI
- Finland
- Prior art keywords
- factor
- binding protein
- neisseria
- binding
- sequence
- Prior art date
Links
- 101710186862 Factor H binding protein Proteins 0.000 title claims 13
- 239000000203 mixture Substances 0.000 title claims 9
- 229960005486 vaccine Drugs 0.000 title claims 2
- 241000588650 Neisseria meningitidis Species 0.000 claims 5
- 102000016550 Complement Factor H Human genes 0.000 claims 4
- 108010053085 Complement Factor H Proteins 0.000 claims 4
- 241000588652 Neisseria gonorrhoeae Species 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 4
- 230000002163 immunogen Effects 0.000 claims 4
- 241000588653 Neisseria Species 0.000 claims 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
- 206010018612 Gonorrhoea Diseases 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 201000009906 Meningitis Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0819633.9A GB0819633D0 (en) | 2008-10-25 | 2008-10-25 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3501534T3 true FI3501534T3 (fi) | 2024-02-09 |
Family
ID=40133849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP18209661.0T FI3501534T3 (fi) | 2008-10-25 | 2009-10-26 | Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20120052092A1 (https=) |
| EP (2) | EP3501534B1 (https=) |
| JP (2) | JP5676458B2 (https=) |
| KR (3) | KR20110092282A (https=) |
| CN (2) | CN105412920A (https=) |
| AU (1) | AU2009306114B2 (https=) |
| BR (1) | BRPI0919926A2 (https=) |
| CA (1) | CA2741619A1 (https=) |
| CO (1) | CO6382140A2 (https=) |
| DK (1) | DK3501534T5 (https=) |
| ES (1) | ES2970878T3 (https=) |
| FI (1) | FI3501534T3 (https=) |
| GB (1) | GB0819633D0 (https=) |
| HR (1) | HRP20240226T1 (https=) |
| HU (1) | HUE065348T2 (https=) |
| LT (1) | LT3501534T (https=) |
| MX (1) | MX2011004322A (https=) |
| NZ (2) | NZ601538A (https=) |
| PL (1) | PL3501534T3 (https=) |
| PT (1) | PT3501534T (https=) |
| RU (1) | RU2559528C2 (https=) |
| SI (1) | SI3501534T1 (https=) |
| WO (1) | WO2010046715A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2261338A3 (en) | 1998-05-01 | 2012-01-04 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
| NZ515935A (en) | 1999-05-19 | 2004-01-30 | Chiron S | Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis |
| JP2004508801A (ja) | 1999-10-29 | 2004-03-25 | カイロン ソチエタ ア レスポンサビリタ リミタータ | ナイセリア抗原性ペプチド |
| NZ521531A (en) | 2000-02-28 | 2005-12-23 | Chiron S | Heterologous expression of neisserial proteins |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| HUE031886T2 (en) | 2002-10-11 | 2017-08-28 | Glaxosmithkline Biologicals Sa | Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| CN102356089B (zh) | 2008-02-21 | 2014-02-19 | 诺华股份有限公司 | 脑膜炎球菌fHBP多肽 |
| AU2009223613B2 (en) | 2008-03-10 | 2014-09-25 | Children's Hospital & Research Center At Oakland | Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use |
| EP2411048B1 (en) | 2009-03-24 | 2020-05-06 | GlaxoSmithKline Biologicals SA | Adjuvanting meningococcal factor h binding protein |
| CA2759400A1 (en) | 2009-04-30 | 2010-11-04 | Children's Hospital & Research Center At Oakland | Chimeric factor h binding proteins (fhbp) and methods of use |
| CA2779816A1 (en) * | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
| CA2792687A1 (en) * | 2010-03-10 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| TR201802933T4 (tr) | 2010-03-30 | 2018-03-21 | Childrens Hospital & Res Center At Oakland | Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi. |
| AU2011268507B2 (en) | 2010-06-25 | 2014-08-14 | Novartis Ag | Combinations of meningococcal factor H binding proteins |
| EP3299467B1 (en) | 2012-02-02 | 2021-08-11 | GlaxoSmithKline Biologicals SA | Promoters for increased protein expression in meningococcus |
| AU2013276083B2 (en) | 2012-06-14 | 2018-04-05 | Institut Pasteur | Vaccines for serogroup X meningococcus |
| WO2014016152A1 (en) | 2012-07-27 | 2014-01-30 | Institut National De La Sante Et De La Recherche Medicale | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| WO2014140562A1 (en) * | 2013-03-14 | 2014-09-18 | Isis Innovation Limited | Immunogenic composition to neisseria |
| CN105431167A (zh) | 2013-08-02 | 2016-03-23 | 奥克兰儿童医院及研究中心 | 非天然发生因子h结合蛋白(fhbp)及其使用方法 |
| KR20160127104A (ko) | 2014-02-28 | 2016-11-02 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 변형된 수막구균 fhbp 폴리펩티드 |
| KR102761870B1 (ko) | 2014-07-23 | 2025-02-05 | 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 | 인자 h 결합 단백질 변이체 및 이의 사용 방법 |
| CN107074939B (zh) * | 2014-08-20 | 2021-09-07 | 桑昆血液供给基金会 | H因子增强抗体及其用途 |
| GB201614687D0 (en) * | 2016-08-31 | 2016-10-12 | Univ Oxford Innovation Ltd | fHbp scaffold |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| EP3897706A4 (en) | 2018-12-21 | 2022-11-23 | Griffith University | COMPOSITIONS, METHODS AND USES FOR INDURING AN IMMUNE RESPONSE |
| EP3997108A4 (en) * | 2019-07-08 | 2024-03-20 | Crapaud Bio, Inc. | METHODS OF PRODUCING AND USING LIPOOLIGOSACCHARIDE COMPOSITIONS AND VACCINES |
| TWI851771B (zh) | 2019-07-17 | 2024-08-11 | 美商雙子治療子公司 | 因子ｈ增強抗體及其用途 |
| US12053516B2 (en) | 2021-02-19 | 2024-08-06 | Sanofi Pasteur Inc. | Meningococcal B recombinant vaccine |
| TW202423477A (zh) | 2022-08-03 | 2024-06-16 | 美商賽諾菲巴斯德公司 | 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| US5476784A (en) * | 1993-04-06 | 1995-12-19 | Rice; Peter A. | Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| BRPI0409459A (pt) * | 2003-04-16 | 2006-05-02 | Wyeth Corp | novas composições imunogênicas para a prevenção e tratamento de doença meningocócica |
| WO2006081259A2 (en) * | 2005-01-27 | 2006-08-03 | Children's Hospital & Research Center At Oakland | Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| US8039007B2 (en) * | 2006-06-29 | 2011-10-18 | J. Craig Venter Institute, Inc. | Polypeptides from Neisseria meningitidis |
| CN102596240B (zh) * | 2009-08-27 | 2015-02-04 | 诺华股份有限公司 | 包括脑膜炎球菌fHBP序列的杂交多肽 |
| TR201802933T4 (tr) * | 2010-03-30 | 2018-03-21 | Childrens Hospital & Res Center At Oakland | Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi. |
-
2008
- 2008-10-25 GB GBGB0819633.9A patent/GB0819633D0/en not_active Ceased
-
2009
- 2009-10-26 KR KR1020117011885A patent/KR20110092282A/ko not_active Ceased
- 2009-10-26 CA CA2741619A patent/CA2741619A1/en not_active Abandoned
- 2009-10-26 CN CN201510119007.XA patent/CN105412920A/zh active Pending
- 2009-10-26 BR BRPI0919926A patent/BRPI0919926A2/pt not_active Application Discontinuation
- 2009-10-26 DK DK18209661.0T patent/DK3501534T5/da active
- 2009-10-26 PT PT182096610T patent/PT3501534T/pt unknown
- 2009-10-26 WO PCT/GB2009/051439 patent/WO2010046715A1/en not_active Ceased
- 2009-10-26 ES ES18209661T patent/ES2970878T3/es active Active
- 2009-10-26 NZ NZ601538A patent/NZ601538A/en not_active IP Right Cessation
- 2009-10-26 EP EP18209661.0A patent/EP3501534B1/en active Active
- 2009-10-26 CN CN2009801480003A patent/CN102245202A/zh active Pending
- 2009-10-26 US US13/125,957 patent/US20120052092A1/en not_active Abandoned
- 2009-10-26 AU AU2009306114A patent/AU2009306114B2/en not_active Ceased
- 2009-10-26 KR KR1020167035443A patent/KR20170000390A/ko not_active Ceased
- 2009-10-26 HU HUE18209661A patent/HUE065348T2/hu unknown
- 2009-10-26 FI FIEP18209661.0T patent/FI3501534T3/fi active
- 2009-10-26 KR KR1020197002691A patent/KR20190011836A/ko not_active Ceased
- 2009-10-26 RU RU2011120706/10A patent/RU2559528C2/ru not_active IP Right Cessation
- 2009-10-26 LT LTEP18209661.0T patent/LT3501534T/lt unknown
- 2009-10-26 NZ NZ592444A patent/NZ592444A/xx unknown
- 2009-10-26 JP JP2011532725A patent/JP5676458B2/ja not_active Expired - Fee Related
- 2009-10-26 PL PL18209661.0T patent/PL3501534T3/pl unknown
- 2009-10-26 SI SI200932190T patent/SI3501534T1/sl unknown
- 2009-10-26 HR HRP20240226TT patent/HRP20240226T1/hr unknown
- 2009-10-26 EP EP09753188.3A patent/EP2355845B1/en not_active Not-in-force
- 2009-10-26 MX MX2011004322A patent/MX2011004322A/es active IP Right Grant
-
2011
- 2011-05-05 CO CO11055224A patent/CO6382140A2/es not_active Application Discontinuation
-
2014
- 2014-12-25 JP JP2014261910A patent/JP6076326B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3501534T3 (fi) | Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia | |
| NZ595063A (en) | Polypeptides from neisseria meningitidis | |
| JP2012506411A5 (https=) | ||
| MX2009006760A (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedades meningococicas. | |
| PH12018501517A1 (en) | Neisseria meningitidis compositions and methods thereof | |
| NZ622048A (en) | Hybrid polypeptides including meningococcal fhbp sequences | |
| EP3533461A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
| MXPA05011110A (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos. | |
| WO2010037395A3 (en) | Mhc multimers in cancer vaccines and immune monitoring | |
| JP2010011868A5 (https=) | ||
| WO2009039854A8 (en) | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics | |
| JP2016040284A5 (https=) | ||
| EP2332961A3 (en) | Novel immunogenic compositions for the prevention and treatment of meningococcal disease | |
| JP2008530245A5 (https=) | ||
| UA99659C2 (uk) | Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування | |
| MX344015B (es) | Vacunas y diagnostico para torque teno virus porcino. | |
| NZ595378A (en) | Immunology treatment for biofilms | |
| WO2011053789A3 (en) | Pharmaceutical composition and methods to enhance cytotoxic t-cell recognition and maintain t-cell memory against a pathogenic disease | |
| JP2013542942A5 (https=) | ||
| WO2010062570A3 (en) | COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE | |
| WO2009072555A1 (ja) | 癌ワクチン | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| NZ593200A (en) | Peptide adjuvants | |
| AR058736A1 (es) | Peptidos mimeticos de carbohidratos y su empleo en formulaciones farmaceuticas | |
| RU2333007C3 (ru) | Полипептидные вакцины для широкой защиты против рядов поколений менингококков с повышенной вирулентностью |